Latest Breaking News On - Zydus announce exclusive licensing agreement - Page 1 : comparemela.com

2023-1211 Daewoong Pharmaceutical and Zydus Announce Exclusive Licensing Agreement for Development and Commercialization of Leuprolide Long-Acting Injectable in the U.S. .

Kyongsang buktoSouth koreaSoult ukpyolsiUnited statesSouth koreanSengho jeonSharvil patelDaewoong pharmaceutical co ltdZydus lifesciences ltdZydus announce exclusive licensing agreement for developmentCadila healthcareZydus groupDaewoong pharmaceuticalZydus announce exclusive licensing agreementLeuprolide long acting injectableZydus worldwide